Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas. [electronic resource]
Producer: 19960905Description: 636-40 p. digitalISSN:- 0959-8049
- Adult
- Antibodies, Anti-Idiotypic -- blood
- Antibodies, Monoclonal -- adverse effects
- Brain Neoplasms -- therapy
- Disease Progression
- ErbB Receptors -- immunology
- Female
- Glioblastoma -- therapy
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- blood
- Prospective Studies
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.